NEWS ER
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
Positive
Revenue increased 10% YoY and 20% QoQ to $0.87M
Higher-margin cartridge sales now exceed reader revenue
Secured 22 new accounts with combined 152,000 employee headcount
International sales increased by 15%
Completed in-clinic portion of FDA 510(k) study
Positive
Revenue increased 10% YoY and 20% QoQ to $0.87M
Higher-margin cartridge sales now exceed reader revenue
Secured 22 new accounts with combined 152,000 employee headcount
International sales increased by 15%
Completed in-clinic portion of FDA 510(k) study
Negative
Net loss increased to $2.70M from $2.43M YoY
Cash position decreased to $3.99M from $6.30M in June 2024
Operating expenses increased to $3.20M from $2.87M YoY
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2607Followers
107Following
28KVisitors
Follow